Literature DB >> 22413053

Primary cutaneous aspergillosis in an immunocompetent patient.

Chubado Tahir1, Musa Garbati, Haruna A Nggada, Edith H Terna Yawe, Auwal M Abubakar.   

Abstract

We present a 32-year-old woman with primary cutaneous aspergillosis and an apparently normal immune status. She is a dietitian who carried out research on Aspergillus contamination of palm oil over a six-month period, during which she apparently shaved her axillae and perineum using a safety razor blade. She presented with nodular lesions, which became extensive ulcers after an attempt at incision and drainage. Diagnosis was based on culture and histology. The patient was treated with itraconazole 200 mg twice a day, with surgical excision and a rhomboid flap cover of the axillae. She has remained disease-free five years after discharge. This highlights the likely benefits of a combination of surgical excision and drug therapy, in achieving a cure in this patient.

Entities:  

Keywords:  Aspergillus; cutaneous; immunocompetent; surgery

Year:  2011        PMID: 22413053      PMCID: PMC3296442          DOI: 10.4103/2006-8808.92802

Source DB:  PubMed          Journal:  J Surg Tech Case Rep        ISSN: 2006-8808


INTRODUCTION

Aspergillus species is the second most common cause of opportunistic fungal infection in humans after candida albicans. It causes severe infections in immunocompromised patients resulting in high mortality, especially in neonates.[1-4] The usual sites of infections are the lungs, central nervous system (CNS), and sinuses, however, the rare cutaneous infection is usually associated with immunodeficiency. Primary cutaneous infection, especially in immunocompetent patients, is extremely rare, but an increase in prevalence has been noted in the last 20 years. The predisposing factors noted in addition to immunodeficiency include, traumatic inoculation, occlusive dressing for an indwelling catheter, burns, aerosolization of fungi during the renovation of building, and prematurity in neonates.[1-4]

CASE REPORT

A 32-year-old female dietitian was referred to the Plastic Surgery Unit with multiple axillary and perineal ulcers and sinuses, following incision and drainage of slowly growing nodular lesions over a one-year period. There was associated severe weight loss and constipation due to pain. However, there was no history of fever, cough, ingestion of steroids or any immunosuppressant drugs. A year before the onset of symptoms, she conducted a research on aspergillus contamination of palm oil over a six-month period and admitted to shaving her axillae and pubic region with a safety razor several times within that period. Physical examination revealed multiple ulcers in the axillae and multiple ulcers and few discharging sinuses in the perineum. The vaginal and rectal examinations were done under general anesthesia and revealed no communication with the vagina or rectum. [Figures 1a and 1b]. There was no significant finding on systemic examination. The biopsy specimens were taken for culture and histopathology. The results revealed a significant growth of aspergillus species and the histological features confirmed invasive aspergillosis. Other investigations, including a chest x-ray, abdominal ultrasound scan, fasting blood sugar, and Mantoux test were all unremarkable. Human immunodeficiency virus (HIV) screening was negative, PCV was 26%, and ESR 150 mm / hour. A diagnosis of primary cutaneous aspergillus infection was made. She was commenced on itraconazole 200 mg b.i.d and daily wound dressing with pure honey. Two weeks after admission, she had wound excision of the right axilla with rhomboid flap cover. Three weeks later, the left axilla and perineum were done. Immediately after surgery, she had weakness of the left upper limb, which recovered fully with physiotherapy and her wound healed completely [Figures 2a and 2b]. She was discharged and has remained disease-free, five years after discharge.
Figure 1a

Right axillary cutaneous aspergillosis, preoperative

Figure 1b

Cutaneous aspergillosis of the perineum of the same patient, preoperative

Figure 2a

Same patient after surgical excision and rhomboid flap cover

Figure 2b

Perineum after surgical excision and direct closure

Right axillary cutaneous aspergillosis, preoperative Cutaneous aspergillosis of the perineum of the same patient, preoperative Same patient after surgical excision and rhomboid flap cover Perineum after surgical excision and direct closure

DISCUSSION

Primary Cutaneous Aspergillosis (PCA) is a rare disease seen in immunosuppressed patients; it is extremely rare in immunocompetent patients and poses a diagnostic challenge.[1] Cutaneous aspergillosis can be either primary or secondary, which results from disseminated aspergillosis. Primary cutaneous lesions result from direct inoculation of the aspergillus species from trauma, especially in patients on catheter, trauma from an arm board, burns, contaminated dressings, and cases have been reported in the neonatal Intensive Care Units (ICU) from aerosolization of fungi during building renovation. Other predisposing factors include prematurity in neonates, use of steroids and other immunosuppressive drugs, and maceration of skin due to exposure to a warm moist environment for prolonged periods. After Candida albicans, the aspergillus species is the most common cause of human opportunistic fungal infection. The organism is abundant in the environment, the common sources are decaying vegetation, stored grains, and soil.[13-7] Our patient most probably contracted the infection from contaminated palm oil on which she was conducting her research and got inoculated after shaving her axillae and perineum with razor blades several times within the period of that research. The practice of removal of axillary hair with a safety razor is said to increase susceptibility to hidradenitis suppurativa, which is an inflammatory disease of the skin and subcutaneous tissue that occurs in the apocritic gland–bearing area in the axilla, perineum, perianal region, mons pubis, groin, and scrotum.[8] Although over 300 species of aspergillus exist, over 90% of human infection is by Aspergillus fumigatus, typically causing systemic infection involving the lungs, blood, and sinuses; primary skin infection is usually caused by Aspergillus flavus, terreus, niger and utus.[3-59] Primary Cutaneous Aspergillosis may present as erythematous, indurated macules, papules, Plaque or hemorrhagic bullae, which may progress to necrotic ulcers that are covered by black eschar. Nodules and pustular lesions although rare might also occur.[135] Our patient presented with nodules, which ulcerated after attempted incision and drainage in a referral clinic. There have been cases reported in the axillae and perineum of neonates, and in these patients the lesions typically originate as erythematous patches or Plaque that develop into pustules and eventually ulcerate to form necrotic eschars.[69] Treatment for aspergillosis is systemic drug therapy with antifungal drugs like amphotericin B and Itraconazole. Treatment of primary cutaneous fungal infection is controversial, both medical and surgical modalities have been undertaken.[10] However, in the cutaneous disease, surgical excision alone and in some cases in combination with drug therapy has been found to be curative.[359-11] In our patients due to the extent of the lesions, a combination of drug therapy (Itraconazole), surgical excision, and rhomboid flap cover in the axillae was probably the only viable treatment option. Making an early diagnosis of PCA, especially in an immunocompetent patient is a clinical challenge, however, a combination of appropriate treatment with new antifungal drugs and careful considerations of adjunctive surgical therapy should improve the outcome in such patients.[910] This is aptly illuminated in our patient.

CONCLUSION

Early diagnosis, a combination of surgical excision and systemic drug therapy with anti-fungal drugs will improve the outcome in patients with primary cutaneous aspergillosis, by reducing the chances of systemic dissemination and achieving a cure.
  11 in total

1.  Primary cutaneous aspergillosis in an immunocompetent individual.

Authors:  C Ajith; S Dogra; B D Radotra; A Chakrabarti; B Kumar
Journal:  J Eur Acad Dermatol Venereol       Date:  2006-07       Impact factor: 6.166

2.  Primary cutaneous aspergillosis.

Authors:  P V S Prasad; A Babu; P K Kaviarasan; C Anandhi; P Viswanathan
Journal:  Indian J Dermatol Venereol Leprol       Date:  2005 Mar-Apr       Impact factor: 2.545

3.  Primary cutaneous aspergillosis (PCA)--a case report.

Authors:  Jannicke Andresen; Egil André Nygaard; Ketil Størdal
Journal:  Acta Paediatr       Date:  2005-06       Impact factor: 2.299

Review 4.  Neonatal primary cutaneous aspergillosis: case report and review of the literature.

Authors:  Christy A Woodruff; Adelaide A Hebert
Journal:  Pediatr Dermatol       Date:  2002 Sep-Oct       Impact factor: 1.588

Review 5.  Primary cutaneous fungal infection after solid-organ transplantation: report of five cases and review.

Authors:  L M Benedict; S Kusne; J Torre-Cisneros; S J Hunt
Journal:  Clin Infect Dis       Date:  1992-07       Impact factor: 9.079

6.  Primary cutaneous aspergillosis in an immunocompetent patient.

Authors:  Clara Romano; Clelia Miracco
Journal:  Mycoses       Date:  2003-02       Impact factor: 4.377

Review 7.  Difficult wounds: an update.

Authors:  Richard F Edlich; Kathryne L Winters; L D Britt; William B Long; K Dean Gubler; David B Drake
Journal:  J Long Term Eff Med Implants       Date:  2005

8.  Primary cutaneous aspergillosis in a premature neonate.

Authors:  R D Granstein; L R First; A J Sober
Journal:  Br J Dermatol       Date:  1980-12       Impact factor: 9.302

9.  Cutaneous infection caused by Aspergillus terreus.

Authors:  Burcin Ozer; Aydiner Kalaci; Nizami Duran; Yunus Dogramaci; Ahmet Nedim Yanat
Journal:  J Med Microbiol       Date:  2009-06-05       Impact factor: 2.472

10.  Primary cutaneous aspergillosis in a heart transplant recipient treated with surgical excision and oral itraconazole.

Authors:  K M Loria; M H Salinger; T G Frohlich; M D Gendelman; F V Cook; C E Arentzen
Journal:  J Heart Lung Transplant       Date:  1992 Jan-Feb       Impact factor: 10.247

View more
  7 in total

1.  Primary cutaneous aspergillosis and idiopathic bone marrow aplasia.

Authors:  Karina Colossi Furlan; Mario Cezar Pires; Priscila Kakizaki; Juliana Cabral Nunes Chartuni; Neusa Yuriko Sakai Valente
Journal:  An Bras Dermatol       Date:  2016 May-Jun       Impact factor: 1.896

2.  Cutaneous aspergillosis masquerading in sporotrichoid morphology in an immunocompetent host.

Authors:  Vikas Pathania; Sunmeet Sandhu; P Sengupta; Kanwaljit Kaur
Journal:  Med J Armed Forces India       Date:  2020-12-31

3.  Primary cutaneous aspergillosis due to Aspergillus tamarii in an immunocompetent host.

Authors:  Sadhna Sharma; Bindu Madhav Yenigalla; Sujeet Kumar Naidu; Premalatha Pidakala
Journal:  BMJ Case Rep       Date:  2013-08-22

4.  Cytomorphological Diagnosis of Isolated Cutaneous Aspergillosis in an Immunocompetent Host.

Authors:  Manjari Kishore; Prajwala Gupta; Minakshi Bhardwaj
Journal:  Indian Dermatol Online J       Date:  2018 May-Jun

5.  Primary Cutaneous Aspergillosis in an Immunocompetent Patient: A Case Report from a Tertiary Care Hospital in Chennai.

Authors:  Sathyakamala Ravichandran; Priyadarshini Shanmugam; Ambujavalli Balakrishnan Thayikkannu; Pradeep Elangovan
Journal:  J Lab Physicians       Date:  2022-02-15

Review 6.  Factors affecting patient outcome in primary cutaneous aspergillosis.

Authors:  Alexander M Tatara; Antonios G Mikos; Dimitrios P Kontoyiannis
Journal:  Medicine (Baltimore)       Date:  2016-06       Impact factor: 1.889

Review 7.  Aspergillus Genus and Its Various Human Superficial and Cutaneous Features.

Authors:  Yassine Merad; Hichem Derrar; Zoubir Belmokhtar; Malika Belkacemi
Journal:  Pathogens       Date:  2021-05-23
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.